Multiple steps are involved in the pathogenesis of chronic lymphocytic leukemia (CLL) and various factors are related to its development: cytogenetic aberrations, antigenic triggers activated by ...
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries. It is characterized by the progressive accumulation of mature-appearing yet immunologically dysfunctional B ...
Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...
AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...
Results of MURANO published last week will form the basis of a regulatory filing in patients with relapsed or refractory CLL – but Peter Hillmen, professor of explorational oncology at the ...
In separate, live virtual events, Alvaro Jose Alencar, MD, and Michael E. Williams, MD, discussed third-line options for a patient with relapsed/refractory chronic lymphocytic leukemia (CLL).
Because of this, the symptoms of chronic leukemias tend to be less severe than acute leukemias, and they progress at a far slower rate. Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia ...
The myeloid term also includes these blood-forming tissues. The two remaining lymphocytic leukemia types are called: Acute lymphocytic leukemia (ALL) Chronic lymphocytic leukemia (CLL) These ...